(NASDAQ: MDCX) is a clinical-stage biotech company working on disruptive approaches to cancer and urologic disease. The ...

In his recent confirmation hearing, Gen. Chris Mahoney, the nominee for vice chairman of the US Joint Chiefs of Staff, set ...

The closing of the Offering is expected to occur on or about September 29, 2025, subject to the satisfaction of customary closing conditions. The gross proceeds from the Offering are expected to be ...

The United States Image-guided Therapy Systems Market is poised to reach USD 2.35 billion by 2033, up from USD 1.49 billion ...

Now in their 35th year, the Australian Museum Eureka Prizes continue to highlight some of the nation's most significant science achievements, this year offering a total prize pool of $190,000.

Phylaxis.ai’s innovation combines personalized risk evaluation and awareness tracking in a 10-minute digital tool that empowers Indian women against breast cancer.

This test is available exclusively through CNSide Diagnostics, LLC. as a testing service provided to health care professionals in the U.S.